MedTrace Logo

Combined Intrathecal Morphine and Dexmedetomidine Analgesia

NCT02435537 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2015-05-06

No results posted yet for this study

Summary

The current study investigated the effect of adding dexmedetomidine to intrathecal morphine for postoperative analgesia in cancer patients undergoing major abdominal surgery.

Conditions

  • Postoperative Pain

Interventions

DRUG

Dexmedetomidine (Precedex)

intrathecal administration

DRUG

Bupivacaine

intrathecal 10 mg bupivacaine

DRUG

Morphine

intrathecal 0.5mg morphine

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Saher AB Mohamed, MD · Assisstant professor in Anesthesia and intensive care department, South Egypt Cancer institute, Assiut university, Egypt

  • Hala s Abdel-Ghaffar, MD · Assisstant professor in Anesthesia and intensive care department, faculty of medicine, Assiut university, Egypt.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2015-03-31
Completion
2015-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02435537 on ClinicalTrials.gov